ÂÜÀòÂÒÂ×

Frederick Strathmann is an accomplished professional in the field of diagnostics and clinical applications, currently serving as SVP Global Business, SVP US Business, and SVP Applied and Clinical Business at MOBILion Systems, Inc. since January 2022, where responsibilities include the development of diagnostic strategies and product initiatives in the clinical market. Frederick also holds positions as a board member at Impact Proteomics, CLIA Laboratory Director and Clinical Consultant at Smithers, and Founder & President of 4DQC, LLC, with a focus on quality control software for laboratory medicine. Previous experience includes significant leadership roles at NMS Labs and ARUP Laboratories, alongside academic contributions as an Assistant Professor at the University of Utah School of Medicine. Educational qualifications include an M.B.A. from the University of Utah and several advanced degrees in pathology and clinical chemistry from the University of Rochester and University of Washington.